Fresenius Medical Care AG

FME

DE0005785802

Healthcare Facilities & Services

Market Closed - Xetra Other stock markets 11:36:08 2024-05-10 am EDT			5-day change	1st Jan Change
40.4 ^EUR	+4.18%		+2.90%	+6.43%

May. 11	Fresenius Medical sees up to 2% US dialysis growth by year-end	RE
May. 10	European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3%	MT

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Buy rating from Goldman Sachs

October 23, 2020 at 07:08 am EDT

Veronika Dubajova from Goldman Sachs retains his positive opinion on the stock with a Buy rating. The target price has been lifted and is now set at EUR 87.50 compared to EUR 84.00 before.

Latest news about Fresenius Medical Care AG

Fresenius Medical sees up to 2% US dialysis growth by year-end	May. 11	RE
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3%	May. 10	MT
Health Care Slips as Defensive Investors Rotate to Utilities - Health Care Roundup	May. 08	DJ
Home REIT cuts borrowings, Genflow shares restored	May. 08	AN
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Wednesday Trading	May. 08	MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Deutsche Bank sticks Neutral	May. 08	ZD
Fresenius becomes more optimistic thanks to subsidiary Kabi - exit from Vamed	May. 08	DP
Dpa-AFX Overview: COMPANIES from 08.05.2024 - 15:15	May. 08	DP
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Goldman Sachs maintains a Buy rating	May. 08	ZD
European Midday Briefing : Stocks Buoyed by Some Solid Earnings	May. 08	DJ
Fresenius makes strong start to the year - forecast raised thanks to subsidiary Kabi	May. 08	DP
Fresenius Medical beats earnings expectations, keeps outlook; shares sink	May. 08	RE
German healthcare group Fresenius Q1 EBIT beats expectations	May. 08	RE
Strabag, Porr to Buy Portions of Fresenius' Vamed Group	May. 08	MT
Fresenius Hikes FY24 Outlook	May. 08	MT
EMEA Morning Briefing : Stock Futures Mixed as Earnings in Focus	May. 08	DJ
FRESENIUS MEDICAL CARE : Are the 2025 targets achievable?	May. 07
Sector Update: Health Care Stocks Advance in Late Afternoon Trading	May. 07	MT
Fresenius raises forecast thanks to good business at subsidiary Kabi	May. 07	DP
Sector Update: Health Care	May. 07	MT
Fresenius Medical Care Shares Decline Following Q1 Results	May. 07	MT
Criticism and final approval for Lufthansa course	May. 07	DP
Bank Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher Tuesday	May. 07	MT
Dpa-AFX Overview: COMPANIES from 07.05.2024 - 15:15	May. 07	DP
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Berenberg reiterates its Buy rating	May. 07	ZD

Chart Fresenius Medical Care AG

Duration

Period

More charts

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.

Sector

Healthcare Facilities & Services

Calendar

2024-05-16 - Annual General Meeting

Related indices

STOXX EUROPE 600 (EUR) , MDAX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

FRESENIUS MEDICAL CARE : Are the 2025 targets achievable?

May 07, 2024 at 04:46 pm EDT

More Strategies

Ratings for Fresenius Medical Care AG

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

40.4 EUR

Average target price

39.45 EUR

Spread / Average Target

-2.34%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
FRESENIUS MEDICAL CARE AG	+6.43%	12.77B
HCA HEALTHCARE, INC.	+20.68%	85.55B
CVS HEALTH CORPORATION	-29.31%	70.07B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+9.65%	29.06B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-8.63%	17.51B
FRESENIUS SE & CO. KGAA	+2.14%	17.39B
QUEST DIAGNOSTICS INCORPORATED	+0.39%	15.38B
REDE D'OR SÃO LUIZ S.A.	+6.47%	13.4B
NATERA, INC.	+68.09%	12.87B
TENET HEALTHCARE CORPORATION	+68.23%	12.42B

Other Healthcare Facilities & Services

Fresenius Medical Care AG

Equities

FME

DE0005785802

Healthcare Facilities & Services

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Buy rating from Goldman Sachs

EPS Revisions